Clinical significance of BIM deletion polymorphism in chemoradiotherapy for non‐small cell lung cancer

The standard treatment for locally advanced non‐small cell lung cancer (NSCLC) is chemoradiotherapy (CRT) followed by anti‐programmed cell death‐ligand 1 (anti‐PD‐L1) treatment. BIM deletion polymorphism induces the suppression of apoptosis resulting from epidermal growth factor (EGFR)‐tyrosine kina...

Descripción completa

Detalles Bibliográficos
Autores principales: Wakabayashi, Yu, Masuda, Takeshi, Fujitaka, Kazunori, Nakashima, Taku, Okumoto, Joe, Shimoji, Kiyofumi, Nishimura, Yoshifumi, Yamaguchi, Kakuhiro, Sakamoto, Shinjiro, Horimasu, Yasushi, Miyamoto, Shintaro, Iwamoto, Hiroshi, Ohshimo, Shinichiro, Hamada, Hironobu, Hattori, Noboru
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Clinical Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7780054/
https://www.ncbi.nlm.nih.gov/pubmed/33103296
http://dx.doi.org/10.1111/cas.14711

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7780054/
https://www.ncbi.nlm.nih.gov/pubmed/33103296
http://dx.doi.org/10.1111/cas.14711

Ejemplares similares